PharmaceuticalField the gateaway to a commercial career is pharma

News

image description

Sales growth driven by COPD therapy Spiriva and the anticoagulant Pradaxa

Read more

Expected to be a huge blockbuster, LCZ696 has become the first non-cancer therapy likely to be included in the Early Access to Medicines Scheme.

Read more

Licensing deal worth up to $555 million

Read more

Miconazole (for athlete's foot) and clobetasol - may activate stem cells to stimulate myelin-producing cells and repair white matter, damaged in MS. Very early-stage though

Read more

Such a combination "is without sound industrial logic or cultural fit"

Read more

Agency says results should be publicly reported within 12 months of a trial’s end, whether a success or failure

Read more

Phase III trial stopped early for already-approved therapy as progression-free survival primary endpoint is met

Read more

First new treatment for CHF to be approved in the USA in nearly a decade

Read more

Green lights for Ariad leukaemia therapy Iclusig, Bayer GIST treatment Stivarga and BI's Vargatef for lung cancer

Read more

Will enable doctors and researchers to draw on real-time insights from data 'at a scale never before possible'

Read more

Field force concerned about Patient First programme and GSK's new incentive scheme

Read more

Have Your Say

No running polls,
please check back
soon.

Pf Archive

Increase your knowledge. Browse the Pf Archive.





Search

Upload
Your CV

Register

Quick Job Search

Looking to make a move? Find your next job here.

Go

RSS
Updates

Subscribe

Career Centre

Need career advice? Visit
our Career
Centre.

Go